Start Date
October 31, 2013
Primary Completion Date
November 30, 2014
Study Completion Date
November 30, 2014
aflibercept
2.0 mg intravitreal aflibercept injection is formulated as a sterile liquid to a final concentration of 40 mg/mL aflibercept in 5% sucrose, 10 mM sodium phosphate pH 6.3, 0.03% polysorbate 20, and 40 mM NaClvs. placebo
Ns/Lij Meeth, New York
Collaborators (1)
Northwell Health
OTHER
Manhattan Eye, Ear & Throat Hospital
OTHER